Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rhian McNaughton"'
Autor:
Victor M. Villalobos, Gary Mo, Mark Agulnik, Seth M. Pollack, Daniel A. Rushing, Arun Singh, Brian A. Van Tine, Rhian McNaughton, Rodney L. Decker, Wei Zhang, Ashwin Shahir, Damien M. Cronier
Publikováno v:
Cancer Medicine, Vol 9, Iss 3, Pp 882-893 (2020)
Abstract Background Olaratumab, a fully human monoclonal antibody, selectively binds to human platelet‐derived growth factor receptor alpha and blocks ligand binding. This study assessed the effect of olaratumab on the pharmacokinetics (PK) of doxo
Externí odkaz:
https://doaj.org/article/ea5713e478994fba9c19d01324de61f2
Autor:
Damien M. Cronier, Seth M. Pollack, Arun S. Singh, Gary Mo, Ashwin Shahir, Daniel A. Rushing, Mark Agulnik, Victor M. Villalobos, Brian A. Van Tine, Rodney Decker, Wei Zhang, Rhian McNaughton
Publikováno v:
Cancer Medicine, Vol 9, Iss 3, Pp 882-893 (2020)
Cancer Medicine
Cancer Medicine
Background Olaratumab, a fully human monoclonal antibody, selectively binds to human platelet‐derived growth factor receptor alpha and blocks ligand binding. This study assessed the effect of olaratumab on the pharmacokinetics (PK) of doxorubicin a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aef460301e43809b610c3fd41cb57cba
https://doaj.org/article/ea5713e478994fba9c19d01324de61f2
https://doaj.org/article/ea5713e478994fba9c19d01324de61f2
Autor:
Elizabeth Lynn, Deborah Layton, Abigail L. Coughtrie, Saad A. W. Shakir, Vicki Osborne, Rhian McNaughton
Publikováno v:
Drug Safety
Introduction Fluenz Tetra is an intranasal quadrivalent live attenuated influenza vaccine (QLAIV) and is recommended as the vaccine of choice for children in the 2014/2015 influenza season vaccination programme in the UK. Objective The primary object
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5885a90701de06e5da260520df4e1adf
http://europepmc.org/articles/PMC4796333
http://europepmc.org/articles/PMC4796333
Autor:
Sara M. Tolaney, Anwar Hossain, Michael Chisamore, Yanyun Chen, J. Thad Beck, Hope S. Rugo, Rhian McNaughton, Hans Wildiers, Peter Kabos, Guy Jerusalem
Publikováno v:
Cancer Research. 80:CT108-CT108
Background: Abemaciclib is an orally administered, selective small molecule cyclin-dependent kinase (CDK) 4 and 6 inhibitor, approved to treat HR+, HER2- mBC pts on a continuous twice daily dosing schedule as monotherapy or in combination with endocr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7b07b86e2090a50c0d7e6b31422a0fd
https://doi.org/10.1158/1538-7445.am2020-ct108
https://doi.org/10.1158/1538-7445.am2020-ct108
Publikováno v:
BMJ Open
Objectives The objective of this study was to determine the nature of evidence used to support the withdrawal of marketing authorisations of drug products for safety reasons throughout the European Union (EU) between 2002 and 2011. Setting Products w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6c14ff94f1f9ca6991693afec71bfe0
http://europepmc.org/articles/PMC3902466
http://europepmc.org/articles/PMC3902466